Cambridge Epigenetix

cambridge-epigenetix

Cambridge Epigenetix is a biotech company in London, United Kingdom, founded in 2012. It has raised $144.5M across 4 rounds, most recently an $88.0M Series D in November 2021.

Headquarters
London, England
Employees
11–50
Founded
2012
Business Model
B2B
Total Funding
$144.5M
Last Round
$88.0M Series DNov 2021
Rounds
4

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 4 funding rounds and 9 investors for this company. to use credits for reveals, or explore the API.

About

Cambridge Epigenetix (now rebranded as biomodal) is a life sciences tools company revolutionizing genome sequencing by enabling simultaneous genetic and epigenetic analysis from a single DNA sample. Its duet multiomics platform distinguishes multiple cytosine modifications to provide a 6-base genome view, enabling earlier and more accurate detection of cancer and other diseases through liquid biopsy and research applications.

Funding History

Data from Indexed.vcUpdated
Series DSeries DNov 2021
$88.0M

3 more funding events

  • Series C20185 investors
  • Series B20164 investors
  • Series A3 investors

Funding: Series B through Series D. Amounts, valuations, and investors where available.

Investors

Tech & App Stack

8 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

  • Cloud/Infrastructure ×4
  • Frontend ×1
  • HR & Finance ×1
  • Marketing & SEO ×1
  • Other ×1

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Companies in related industries

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Cambridge Epigenetix on Indexed.vc
<a href="https://indexed.vc/companies/cambridge-epigenetix"><img src="https://indexed.vc/api/badge/company/cambridge-epigenetix" alt="Cambridge Epigenetix on Indexed.vc" width="260" height="76" /></a>